Tijaria Polypipes DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.00×1.00×1.00×1.00×1.00×
1.37×1.26×2.10×0.95×1.24×
———−2,067.7%−54.9%
0.00×0.00×0.00×0.00×0.23×
−1.44×−1.44×−1.68×−2.01×−2.55×
———0.0%40.0%
3.9%3.9%18.2%11.4%39.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

TIJARIA₹5.00

Tijaria Polypipes Limited

· Capital Goods & Defence
₹ CrorePeersJISLDVREQSTEXMOPIPESTAINWALCHMKRITIPREMIERPOLJAICORPLTDJISLJALEQSMcap ₹14.3 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×1.001.001.001.001.00
Interest Burden (Pretax/EBIT) ×1.240.952.101.261.37
EBIT Margin %-54.87-2,067.68———
Asset Turnover ×0.230.000.000.000.00
Financial Leverage (Assets/Equity) ×-2.55-2.01-1.68-1.44-1.44
ROE (5-step product, year-end total equity) %40.000.00———
ROE (owners' profit / average owners' equity) %39.1411.3918.233.883.88
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.